TRANEXAMIC ACID IN CAESAREAN DELIVERY: PROPHYLACTIC USE VERSUS USE AS DEFINITIVE TREATMENT FOR POSTPARTUM HAEMORRHAGE

Authors

  • Dr Devendra Prasad Bairwa Author

DOI:

https://doi.org/10.48047/

Keywords:

Tranexamic acid; caesarean delivery; postpartum haemorrhage; prophylaxis; haemorrhage treatment; maternal morbidity; systematic review.

Abstract

Background: Postpartum haemorrhage (PPH) remains an important cause of maternal morbidity and mortality. Tranexamic acid (TXA), an antifibrinolytic agent, has been studied both to reduce blood loss around caesarean delivery and as treatment after clinically diagnosed PPH. These applications address different clinical questions and should not be considered interchangeable. Objective: To synthesize evidence available up to 31 December 2020 regarding prophylactic TXA in caesarean delivery and TXA for established PPH

Downloads

Download data is not yet available.

Downloads

Published

2020-12-15

Issue

Vol. 11 No. 11 (2020): volume 11 issue 11 (2020)

Section

Articles